Why is the Texas stem cell company Celltex so super duper private about itself? I’m not sure. It has been the subject of much discussion in the stem cell field in the past year. Unfortunately, much of the news has been negative, largely related to their former head of ethics, Glenn McGee, who also was […]
Wondering why Celltex is still so silent Read More »
I’ve found myself in the middle of an international kerfuffle over stem cell research in Ireland related to my post commenting on an article (You can read that article here, but warning you have to pay a bit to read it) in The Daily Business Post by reporter Susan Mitchell of Ireland on the topic. The
My response to a stern email from Adult Stem Cell Foundation of Ireland Read More »
A new article out by Susan Mitchell covers the key elements of a brewing, serious conflict in Ireland over stem cells. You can read the piece here, but warning you have to pay to read it. Here in this blog post I analyze the situation and give important quotes from the article. A pro-adult stem
Stem Cell Conflict Erupting in Ireland Read More »
Recently, there has been a brewing controversy surrounding a journal called American Journal of Bioethics (AJOB), a company called CellTex, a bioethicist named Dr. Glenn McGee who founded and used to run AJOB until he recently resigned, and two University of Minnesota professors, Drs. Carl Elliott and Leigh Turner who have been publicly critical of
Celltex versus University of Minnesota: support for Elliott and Turner Read More »
How can I make money from stem cells? Someone recently asked me this question and more often I get asked “Which stem cell companies do YOU like as a stem cell scientist?” Just today an article went out that said that the global market for stem cell products will be $65 billion by 2015. That’s
How to make money from stem cells Read More »
Gene editing continues to advance both in the clinic trial arena and at more basic science levels including a report on a new approach called click editing. The two gene editing papers below highlight the variety of tools now available. Gene Editing papers including click editing Click editing enables programmable genome writing using DNA polymerases
Recommended reads: click editing, CRISPR v. progeria, diapause transcriptional program Read More »
Almost two years ago I publicly called on the FDA to freeze the unproven cord cell expanded access program (EAP) at the Duke Autism Center. Duke has been infusing kids with autism spectrum disorder (ASD) with unproven cord cells and requiring large payments for this. The cost was as much as $15,000. A halt and a
Why did Duke autism team halt its troubling pay-for-play program? Read More »
It’s that time of year again when I grade my previous year’s predictions for the stem cell & regenerative medicine space. Overall, I did better than a typical year. I give the 2022 predictions an A- overall. This exercise can be kind of fun but also humbling. For example, I tend to be too optimistic
Grading my 2022 regenerative medicine predictions Read More »
Viacord is one of the most well known firms in the for-profit cord blood banking industry. Today’s post is a review of the firm. I see concrete reasons for concern. What is Viacord? | Dubious autism claims | Viacord cost | Overall Review | References What is Viacord? As a cord blood banking firm, Viacord freezes
Review of cord banker Viacord: dubious autism claims & other concerns Read More »
What do a Panama stem cell clinic and the Duke Autism Center have in common? More than I might have imagined. It’s a remarkable story that needs telling. Duke Autism Center There is a puzzle when it comes to the controversial idea of using cord blood for autism. Why? Because two of the strongest proponents
Duke Autism Center has Panama clinic to thank for $10s millions? Read More »